Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 18.58.
Forward PE Ratio (18.58) = Close Price ($32.04) / Consensus Forward EPS ($1.72)
FORWARD PE RATIO
18.58
SECTOR MEDIAN · HEALTHCARE
19.91
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
-6.70%
vs the sector median at left
Oscar Health, Inc.
Market Cap
$8.31B
Forward PE Ratio
18.58
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Oscar Health, Inc. (OSCR) | $8.31B | 18.58 |
| Hims & Hers Health, Inc. (HIMS)vs › | $7.54B | N/A |
| Henry Schein, Inc. (HSIC)vs › | $10.08B | 16.44 |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $10.23B | 39.42 |
| Insulet Corp. (PODD)vs › | $10.26B | 22.78 |
| Molina Healthcare, Inc. (MOH)vs › | $10.46B | N/A |
| Universal Health Services, Inc. (UHS)vs › | $10.73B | 7.85 |
| DaVita Inc. (DVA)vs › | $11.16B | 11.71 |
| Bio-Techne Corporation (TECH)vs › | $11.32B | 37.61 |
| Align Technology, Inc. (ALGN)vs › | $11.64B | 14.40 |
Trailing P/E
22.9
reported TTM EPS
Forward P/E
18.6
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $1.72 implies +22.9% EPS growth vs the reported trailing $1.40.
At today's $32.04 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-12-31 | $1.72 | $1.54 – $1.85 | 6 | 18.6x |
| 2027-12-31 | $1.90 | $1.45 – $2.39 | 6 | 16.8x |
| 2028-12-31 | $2.46 | $2.25 – $2.60 | 5 | 13.0x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
